Essential Tremor
Pipeline by Development Stage
Competitive Landscape
23 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 5,884 patients across 50 trials
Pregabalin (Lyrica) for the Treatment of Essential Tremor
A Pilot Clinical Trial Of Memantine for Essential Tremor
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.
A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
A Clinical Trial of PRAX-114 in Participants With Essential Tremor
Study to Evaluate SAGE-324 in Participants With Essential Tremor
A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)
A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor
Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor
A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor
A Clinical Trial of PRAX-944 in Participants With Essential Tremor
A Phase 2 RCT Study of CX-8998 for Essential Tremor
A Study to Evaluate SAGE-217 in Participants With Essential Tremor
An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor
Evaluate SAGE-547 in Participants With Essential Tremor
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor
A Safety/Efficacy Trial of Zonisamide for Essential Tremor
Trial of Cannabis for Essential Tremor
ExAblate Transcranial MR Guided Focused Ultrasound in the Treatment of Essential Tremor
ExAblate Transcranial MR Guided Focused Ultrasound in the Treatment of Essential Tremor
Pregabalin in the Treatment of Essential Tremor
Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor
Neuromodulation Strategies for Treatment-Resistant Essential Tremor Using Chronos™ DBS
EMBRACE Tremor BiFUS
Home Use Study of Targeted Mechanical Stimulation for Tremor Relief
Directional Bilateral Thalamic Patterned Stimulation (Chronos)
Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor
Upper Limb Tremor Reduction in Essential Tremor Patients
Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor
Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)
Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands
RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor
Directional Versus Nondirectional DBS for ET
Physiology, Imaging and Modeling of Essential Tremor
Environmental Epidemiology of Essential Tremor
Bilateral Treatment of Medication Refractory Essential Tremor
Dual Lead Thalamic Deep Brain Recording (DBR)-DBS Interface for Closed Loop Control of Severe Essential Tremor
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool
Long-Term Transcutaneous Stimulation and Essential Tremor: A PET Study
Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
Prospective Study for Symptomatic Relief of ET With Cala Therapy
Wearable Sensor for Responsive DBS for ET
A Pilot Study of the Cala ONE Device for Essential Tremor
Responsive Deep Brain Stimulator for Essential Tremor
The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients
Cala ONE Device for Essential Tremor
Deep braIn Stimulation for Tremor TractographIC Versus Traditional
Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.